AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALBUMINE HUMAINE PLASMATIQUE
12 registrations across 1 African market— 0 active
Markets with ALBUMINE HUMAINE PLASMATIQUE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| YDRALBUM Solution injectable / 200 g/l | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 2019 |
| YDRALBUM Solution injectable / 200 g/l | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 2019 |
| ALBIOMIN 5% Solution injectable pour perfusion / 50g/l | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2016 |
| ALBIOMIN Solution injectable / 20% | 🇹🇳Tunisia | BIOTEST PHARMA GmbH | expired | Apr 2015 |
| ALBUNORM Solution injectable pour perfusion / 20% | 🇹🇳Tunisia | OCTAPHARMA pharmazeutika produktionges.m.b.h | expired | Aug 2013 |
| HUMAN ALBUMIN 20% BEHRING Solution injectable | 🇹🇳Tunisia | CSL BEHRING GmbH | expired | Jul 2012 |
| ALBUMINE HUMAINE TAKEDA Solution injectable / 200 gr/l | 🇹🇳Tunisia | Takeda Manufacturing Austria AG | expired | May 2012 |
| UMAN ALBUMIN Solution injectable / 200 gr/l | 🇹🇳Tunisia | KEDRION S.p.A | expired | Mar 2012 |
| ALBUMIN-GCC Solution injectable / 20% | 🇹🇳Tunisia | GREEN CROSS CORPORATION | expired | Aug 2003 |
| ALBUMINATIV Solution injectable pour perfusion / 20% | 🇹🇳Tunisia | OCTAPHARMA AB | expired | Oct 2002 |
| VIALEBEX Solution injectable pour perfusion / 20% | 🇹🇳Tunisia | LFB-Biomédicaments | expired | Nov 1998 |
| VIALEBEX Solution injectable pour perfusion / 20% | 🇹🇳Tunisia | LFB-Biomédicaments | expired | May 1998 |
ALBUMINE HUMAINE PLASMATIQUE in Africa — Regulatory Overview
ALBUMINE HUMAINE PLASMATIQUE is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 0 (0%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.